FAM136BP

Across TCGA pan-cancer cohorts, FAM136BP RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FAM136BP data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FAM136BP RNA is associated with better overall survival. In most high-consensus cancer types, elevated FAM136BP expression acts as an unfavorable survival marker, although some lineages such as COAD and MESO show a favorable association.

COAD, LIHC, and KIRP are the cancer types where FAM136BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Quartile	All	0.866	0.522	.001	68	view →
LIHC	DFS	Tertile	All	0.406	0.628	<.001	66	view →
KIRP	DFS	Quartile	IV	0.030	0.526	<.001	36	view →
READ	DFS	Tertile	II,III,IV	0.424	0.872	<.001	36	view →
UVM	DFS	Tertile	III,IV	0.133	0.725	.003	29	view →
MESO	OS	Tertile	II,III,IV	0.843	0.218	.001	27	view →
PRAD	DFS	Median	All	0.834	0.927	<.001	26	view →
OV	OS	Tertile	IV	0.874	0.663	.006	12	view →
KIRC	DFS	Quartile	II,III,IV	0.606	0.800	.020	10	view →
UCEC	OS	Median	II,III,IV	0.789	0.911	.003	10	view →
KICH	OS	Quartile	II,III,IV	0.610	0.881	.025	9	view →
LGG	OS	Quartile	All	0.849	0.924	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

FAM136BP–COAD (OS)

Open the COAD breakdown →